The findings indicated that PARG inhibitor and X-Ray treatment substantially increased R5P level (Fig. 3I, K), and PARP1 inhibitor treatment significantly decreased R5P level in HCC cells (Fig. 3J). Here, PARP1 is linked to hepatocellular carcinoma.